Tscan therapeutics presents preclinical data at the american society of gene and cell therapy 25th annual meeting

Identified lead tcr-t cell therapy candidate, tcr-200-a02, for the treatment of hpv-positive solid tumors, on track for ind submission in 2h22

TCRX Ratings Summary

TCRX Quant Ranking